C4 Therapeutics to Participate in the Stifel 2023 Virtual Targeted Oncology Days

April 19, 2023

https://www.globenewswire.com/news-release/2023/04/19/2649860/0/en/C4-Therapeutics-to-Participate-in-the-Stifel-2023-Virtual-Targeted-Oncology-Days.html

WATERTOWN, Mass., April 19, 2023 (GLOBE NEWSWIRE) — C4 Therapeutics, Inc. (C4T) (Nasdaq:CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science to develop a new generation of small-molecule medicines and transform how disease is treated, today announced that C4T management will participate in a fireside chat at the Stifel 2023 Virtual Targeted Oncology Days.

Read more at globenewswire.com

Related news for (CCCC)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.